Navigation Links
Chinese Medical Device Market Worth $53.5 billion by 2020 Says a New Research Report at RnRMarketResearch.com
Date:10/23/2013

Dallas, TX (PRWEB) October 24, 2013

The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.

Considerable investment in China’s pharmaceutical Research & Development (R&D) sector, along with numerous government-initiated reforms, will spark soaring growth in the country’s pharmaceutical market in the near future. China is the most populated country in the world. In 2012, its population was approximately 1.3 billion, approximately one fifth of the global population. Growth has however been effectively controlled and has slowed down due to the strict enforcement of family-planning and one-child policies. The decline in the size of the young working-age group and the growing elderly population are however matters of concern for policy planners.

Complete report is available at http://www.rnrmarketresearch.com/countryfocus-healthcare-regulatory-and-reimbursement-landscape-china-market-report.html .

According to the company’s latest report on China’s healthcare industry CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China, the country’s pharmaceutical market value will climb from an estimated $48 billion in 2012 to a massive $315 billion in 2020, at a Compound Annual Growth Rate (CAGR) of 26.5%. This increase will see China’s pharmaceutical market become the second largest in the world, with surging revenue propelling industry value significantly closer to that of the US, which GlobalData forecasts to reach $475 billion in 2020.

An expanding and aging population will also play a key role in boosting China’s pharmaceutical market revenue. With the country’s elderly population expected to account for 19% of its total population of 1.41 billion in 2020, GlobalData expects to see a rising prevalence of chronic diseases, which will in turn spark an increasing demand for treatment. This factor will also be a primary driver behind the rising value of China’s medical device market – the second largest in Asia, behind Japan – which forecasts will climb from $20 billion in 2012 to $54 billion in 2020.

This report identifies the key trends in China’s healthcare market, providing insights into the demographic, regulatory and reimbursement landscape and the country’s healthcare infrastructure, as well as the trends and segmentation of the Chinese pharmaceutical and medical device markets.

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape in China, and includes:

Overview of the pharmaceutical and medical devices markets, comprising market size, segmentation, and key drivers and barriers;

Profiles and SWOT analysis of the major players in the pharmaceutical market, of which the major Multinational Companies (MNCs) were GlaxoSmithKline (GSK), Pfizer, and AstraZeneca; and the major domestic players were Harbin Pharmaceutical Group and Tasly Pharmaceutical Group; and the medical device market, of which the major players were Siemens Healthcare, GE Healthcare, Fresenius Medical Care, GlaxoSmithKline, and Philips Healthcare;

Insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, regulatory agencies, and market authorization processes for new drugs and medical devices;

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure;

An overview of the opportunities for and challenges to growth in the Chinese healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving China’s healthcare market;

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments, and companies likely to impact the healthcare market in the future;

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors;

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investments, and strategic partnerships;

Identify, understand and capitalize on the opportunities and challenges in China’s healthcare market.

Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=111444.

Browse more reports on Regulation Market: http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/regulation-policy/regulation.

Contact sales(at)rnrmarketresearch(dot)com for further information.

About Us:
RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online database of market research reports that offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/healthcare-regulatory/reimbursement-china/prweb11260851.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Combining Chinese and Western medicine could lead to new cancer treatments
2. Chinese Orthopedic Biomaterials Market
3. Chinese OTC Drug Industry 2013 Analysis and 2017 Forecasts in New Research Report at RnRMarketResearch.com
4. Chinese Contract Research Organization Market (CRO) 2013 Analysis in New Research Report at RnRMarketResearch.com
5. 123Greetings Launched Spanish, Chinese, Russian, & Hindi Ecards Under World Languages, Adding Diversity To Its Collection
6. Chinese Traditional Clothing with Discounts Now Online at 4leafcity.com
7. Chinese CDC and Aeras sign agreement to collaborate on TB vaccine R&D
8. UCLA and Chinese scientists analyze genetic makeup of human and mouse embryos in amazing detail
9. 4leafcity.com Has Launched a Promotional Offer on Chinese Traditional Dresses
10. International Food Protection Training Institute Hosts Chinese Delegation
11. Daily QiGong and Chinese Medicine Improves Health Says Alternative Medicine Pioneer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: